Terminal complement components mediate release of von Willebrand factor and adhesion of platelets in arteries of allografts

Transplantation

Volumn 79, Issue 3, 2005, Pages 276-281

  Ota, Hirofumi ^a,b   Fox Talbot, Karen ^a   Hu, Weimin ^a,c   Qian, Zhiping ^a   Sanfilippo, Fred ^a,d   Hruban, Ralph H ^a   Baldwin III, William M ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b Saiseikai Senri Hospital   (Japan)

^c LAKERIDGE HEALTH CORPORATION   (Canada)

^d THE OHIO STATE UNIVERSITY COLLEGE OF MEDICINE   (United States)

Author keywords

Antibody; Complement; Macrophages; Platelets; Von Willebrand factor

Indexed keywords

COMPLEMENT COMPONENT C5; COMPLEMENT COMPONENT C6; CYCLOSPORIN; VON WILLEBRAND FACTOR;

ALLOGRAFT; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTERITIS; ARTERY GRAFT; ARTERY INJURY; ARTICLE; CELLULAR IMMUNITY; COMPLEMENT ACTIVATION; CONGENIC STRAIN; CONTROLLED STUDY; ENDOTHELIUM CELL; ENDOTHELIUM INJURY; FEMALE; GRAFT REJECTION; HEART GRAFT; HUMORAL IMMUNITY; IMMUNE RESPONSE; IN VIVO STUDY; INFLAMMATION; INTIMA; MAJOR HISTOCOMPATIBILITY COMPLEX; MEDIATOR RELEASE; NONHUMAN; ORGAN TRANSPLANTATION; PRIORITY JOURNAL; RAT; STROMA CELL; THROMBOCYTE ADHESION; THROMBOCYTE AGGREGATION;

ANIMALS; COMPLEMENT C3D; COMPLEMENT C6; COMPLEMENT SYSTEM PROTEINS; FEMALE; HEART TRANSPLANTATION; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; ISOANTIBODIES; PLATELET ADHESIVENESS; PLATELET AGGREGATION; RATS; RATS, INBRED STRAINS; TRANSPLANTATION, HOMOLOGOUS; VON WILLEBRAND FACTOR;

EID: 14544301582     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.TP.0000146195.76904.D3     Document Type: Article

References (41)

1. Nickeleit V, Vamvakas EC, Pascual M, et al. The prognostic significance of specific arterial lesions in acute renal allograft rejection. J Am Soc Nephrol 1998; 9: 1301.
2. Kuypers DR, Chapman JR, O'Connell PJ, et al. Predictors of renal transplant histology at three months. Transplantation 1999; 67: 1222.
3. Alpers CE, Gordon D, Gown AM. Immunophenotype of vascular rejection in renal transplants. Mod Pathol 1990; 3: 198.
4. Jeannet M, Finn VW, Flax MH, et al. Humoral antibodies in renal allotransplantation in man. N Engl J Med 1970; 282: 111.
5. Russell PS, Chase CM, Winn HJ, et al. Coronary atherosclerosis in transplanted mouse hearts: II. Importance of humoral immunity. J. Immunol 1994; 152: 5135.
6. Racusen LC, Colvin RB, Solez K, et al. Antibody-mediated rejection criteria: An addition to the Banff 97 classification of renal allograft rejection. Am J Transplant 2003; 3: 708.
7. Halloran PF, Wadgymar A, Ritchie S, et al. The significance of the anti-class I antibody response: I. Clinical and pathological features of anti-class I-mediated rejection. Transplantation 1990; 49: 85.
8. Halloran PF, Schlaut J, Solez K, et al. The significance of the anti-class I response: II. Clinical and pathological features of renal transplants with anti-class I-like antibody. Transplantation 1992; 53: 550.
9. Trpkov K, Campbell P, Pazderka F, et al. The pathology of acute renal allograft rejection associated with donor-specific antibody: Analysis using the Banff grading schema. Transplantation 1996; 61: 1586.
10. Wasowska BA, Qian Z, Cangello DL, et al. Passive transfer of alloantibodies restores acute cardiac rejection in IgKO mice. Transplantation 2001; 71: 727.
11. Jabs WJ, Sedlmeyer A, Ramassar V, et al. Heterogeneity in the evolution and mechanisms of the lesions of kidney allograft rejection in mice. Am J Transplant 2003; 3: 1501.
12. Rahimi S, Qian Z, Layton J, et al. Non-complement- and complement-activating antibodies synergize to cause rejection of cardiac allografts. Am J Transplant 2004; 4: 326.
13. Feucht HE. Complement C4d in graft capillaries: The missing link in the recognition of humoral alloreactivity. Am J Transplant 2003; 3: 646.
14. Kuypers DR, Lerut E, Evenepoel P, et al. C3d deposition in peritubular capillaries indicates a variant of acute renal allograft rejection characterized by a worse clinical outcome. Transplantation 2003; 76: 102.
15. Baldwin WM III, Kasper EK, Zachary AA, et al. Beyond C4d: Other complement related diagnostic approaches to antibody-mediated rejection. Am J Transplant 2004; 4: 311.
16. Ratliff NB, McMahon JT. Activation of intravascular macrophages within myocardial small vessels is a feature of acute vascular rejection in human heart transplants. J Heart Lung Transplant 1995; 14: 338.
17. Michaels PJ, Espejo ML, Kobashigawa J, et al. Humoral rejection in cardiac transplantation: Risk factors, hemodynamic consequences and relationship to transplant coronary artery disease. J Heart Lung Transplant 2003; 22: 58.
18. Magil AB, Tinckam K. Monocytes and peritubular capillary C4d deposition in acute renal allograft rejection. Kidney Int 2003; 63: 1888.
19. Baldwin WM III, Flavahan NA, Fairchild RL. Integration of complement and leukocytes in response to allotransplantation. Curr Opin Transplant 2002; 7: 92.
20. Schraufstatter IU, Trieu K, Sikora L, et al. Complement c3a and C5a induce different signal transduction cascades in endothelial cells. J Immunol 2002; 169: 2102.
21. Brauer RB, Baldwin WM III, Ibrahim S, et al. The contribution of terminal complement components to acute and hyperacute allograft rejection in the rat. Transplantation 1995; 59: 288.
22. Wasowska B, Baldwin WM III, Sanfilippo F. IgG alloantibody responses to donor specific blood transfusion in different rat strain combinations are predictive of renal allograft survival. Transplantation 1992; 53: 175.
23. Qian Z, Jakobs FM, Pfaff-Amesse T, et al. Complement contributes to the rejection of complete and class I MHC incompatible cardiac allografts. J Heart Lung Transplant 1998; 17: 470.
24. Qian Z, Wasowska BA, Behrens E, et al. C6 produced by macrophages contributes to cardiac allograft rejection. Am J Pathol 1999; 155: 1293.
25. Wray DW, Baldwin WM III, Sanfilippo F. IgM and IgG alloantibody responses to MHC class I and II following rat renal allograft rejection: Effects of transplantectomy and posttransplantation blood transfusions. Transplantation 1992; 53: 167.
26. Collins P, Wilkie M, Razak K, et al. Cyclosporine and cremaphor modulate von Willebrand factor release from cultured human endothelial cells. Transplantation 1993; 56: 1218.
27. Pober JS, Cotran RZ. The role of endothelial cells in inflammation. Transplantation 1990; 50: 537.
28. Platt JL, Dalmasso AP, Lindman BJ, et al. The role of C5a and antibody in the release of heparan sulfate from endothelial cells. Eur J Immunol 1991; 21: 2887.
29. Foreman KE, Vaporciyan AA, Bonish BK, et al. C5a-induced expression of P-selectin in endothelial cells. J Clin Invest 1994; 94: 1147.
30. Bian H, Reed EF. Alloantibody-mediated class I signal transduction in endothelial cells and smooth muscle cells: Enhancement by IFN-gamma and TNF-alpha. J Immunol 1999; 163: 1010.
31. Saadi S, Holzknecht RA, Patte CP, et al. Complement-mediated regulation of tissue factor activity in endothelium. J Exp Med 1995; 182: 1807.
32. Hattori R, Hamilton KK, McEver RP, et al. Complement proteins C5b-C9 induce secretion of high molecular weight multimers of endothelial von Willebrand factor and translocation of granule membrane protein GMP-140 to the cell surface. J Biol Chem 1989; 264: 9053.
33. Tedesco F, Pausa M, Nardon E, et al. The cytolytically inactive terminal complement complex activates endothelial cells to express adhesion molecules and tissue factor procoagulant activity. J Exp Med 1997; 185: 1619.
34. Selvan RS, Kapadia HB, Platt JL. Complement-induced expression of chemokine genes in endothelium: Regulation by IL-1-dependent and -independent mechanisms. J Immunol 1998; 161: 4388-4395.
35. Saadi S, Holzknecht RA, Patte CP, et al. Endothelial cell activation by pore-forming structures: Pivotal role for interleukin-1 alpha. Circulation 2000; 101: 1867.
36. Kilgore KS, Shen JP, Miller BF, et al. Enhancement by the complement membrane attack complex of tumor necrosis factor-alpha-induced endothelial cell expression of E-selectin and ICAM-1. J Immunol 1995; 155: 1434.
37. Pratt JR, Basheer SA, Sacks SH. Local synthesis of complement component C3 regulates acute renal transplant rejection. Nat Med 2002; 8: 582.
38. Kim AH, Dimitriou ID, Holland MC, et al. Complement C5a receptor is essential for the optimal generation of antiviral CD8+ T cell responses. J Immunol 2004; 173: 2524.
39. Meehan SM, Limsrichamrern S, Manaligod JR, et al. Platelets and capillary injury in acute humoral rejection of renal allografts. Hum Pathol 2003; 34: 533.
40. Qian Z, Hu W, Liu J, et al. Accelerated graft arteriosclerosis in cardiac transplants: Complement activation promotes progression of lesions from medium to large arteries. Transplantation 2001; 72: 900.
41. Ruggeri ZM. von Willebrand factor. J Clin Invest 1997; 99: 559.